Heavily indebted poor countries (HIPC) vs Rwanda: Access to anti-retroviral drugs, male
Heavily indebted poor countries (HIPC)
80.4%
in 2024
Rwanda
95.0%
in 2024
Heavily indebted poor countries (HIPC) rank
6th
Rwanda rank
4th
Access to anti-retroviral drugs, male over time
- Heavily indebted poor countries (HIPC)
- Rwanda
How they compare
Rwanda currently reports 95.0% against 80.4% in Heavily indebted poor countries (HIPC), a difference of 14.6%.
That makes Rwanda's figure about 1.2 times Heavily indebted poor countries (HIPC)'s.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Rwanda ahead.
Heavily indebted poor countries (HIPC) ranks 6th and Rwanda ranks 4th of 19 groups.
Rwanda has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Heavily indebted poor countries (HIPC) | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.7% | 10.4% | 4.7% | Rwanda |
| 2010s | 39.0% | 60.0% | 21.0% | Rwanda |
| 2020s | 72.5% | 90.0% | 17.5% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Heavily indebted poor countries (HIPC) or Rwanda?
- Rwanda, at 95.0% against 80.4% in Heavily indebted poor countries (HIPC) as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Heavily indebted poor countries (HIPC) and Rwanda?
- 14.6%, with Rwanda ahead.
- How many years of comparable data are there for Heavily indebted poor countries (HIPC) and Rwanda?
- 25 years are reported by both, from 2000 to 2024.
- How do Heavily indebted poor countries (HIPC) and Rwanda rank globally for access to anti-retroviral drugs, male?
- Heavily indebted poor countries (HIPC) ranks 6th and Rwanda ranks 4th of 19 groups.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.